Spain· ES:1262065001
TAFAMIDIS ACCORD 61 MG CAPSULAS BLANDAS EFG
A medicinal product containing tafamidis, registered in Spain by Accord Healthcare S.L.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- tafamidis
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tafamidis in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenTafamidis STADA Nordic 61 mg Kapsel, mjukSTADA Nordic ApS
- BelgiumTafamidis EG 61 mgEG
- IrelandVyndaqel 61 mg soft capsulesPfizer Europe MA EEIG
- CzechiaVYNDAQELPfizer Europe MA EEIG, Bruxelles
- FranceVYNDAQEL 61 mg, capsule mollePFIZER EUROPE MA EEIG (BELGIQUE)
- IcelandVyndaqelPfizer Europe MA EEIG*
- NorwayVyndaqelPfizer Europe MA EEIG (1)
- PolandVyndaqelPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Tafamidis Stada, Tafamidis Viatris
- Belgium · Tafamidis Viatris
- Germany · Tafamidis Al, Tafamidis Viatris
- France · Tafamidis Biogaran, Tafamidis Eg
- United Kingdom (Northern Ireland) · Tafamidis Thornton & Ross
- Iceland · Vyndaqel
- Liechtenstein · Vyndaqel
- Norway · Tafamidis Stada Nordic, Tafamidis Viatris
- Sweden · Tafamidis Stada Nordic, Tafamidis Viatris
- Slovenia · Tafamidis Sumar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/98d4f4da-0eec-4b1b-b3de-bd54c5541386 GET /v1/drugs/98d4f4da-0eec-4b1b-b3de-bd54c5541386?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1790186647000}",
"nregistro": "1262065001",
"substance": "tafamidis"
}See everything about tafamidis.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.